Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Memory Disorders × Donepezil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiation Injuries 2 Small Cell Lung Carcinoma 1 Pinealoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Meningioma 1 Memory Disorders 1 Medulloblastoma 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Fatigue 1 Ependymoma 1 Depression 1 Delirium 1 Craniopharyngioma 1 Cognitive Dysfunction 1 Choroid Plexus Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Sugars 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed

276 enrolled 33 charts

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡